Menu
Search
|

Menu

Close
X

Insulet Corp PODD.OQ (NASDAQ Stock Exchange Global Select Market)

88.65 USD
-- (--)
As of 1:30 AM IST
chart
Previous Close 88.65
Open --
Volume --
3m Avg Volume 192,185
Today’s High --
Today’s Low --
52 Week High 102.75
52 Week Low 48.99
Shares Outstanding (mil) 58.06
Market Capitalization (mil) 3,415.65
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.89 Mean rating from 18 analysts

KEY STATS

Revenue (mm, USD)
FY18
124
FY17
464
FY16
367
FY15
264
EPS (USD)
FY18
-0.112
FY17
-0.458
FY16
-0.475
FY15
-1.084
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.76
Price to Sales (TTM)
vs sector
8.33
5.73
Price to Book (MRQ)
vs sector
52.76
5.47
Price to Cash Flow (TTM)
vs sector
--
23.29
Total Debt to Equity (MRQ)
vs sector
526.59
16.84
LT Debt to Equity (MRQ)
vs sector
526.59
12.51
Return on Investment (TTM)
vs sector
-9.66
14.61
Return on Equity (TTM)
vs sector
-64.91
16.34

EXECUTIVE LEADERSHIP

Patrick Sullivan
Chairman of the Board, Chief Executive Officer, Since 2016
Salary: $692,307.00
Bonus: $1,330,000.00
Shacey Petrovic
President, Chief Operating Officer, Since 2016
Salary: $472,115.00
Bonus: $800,000.00
Michael Levitz
Chief Financial Officer, Senior Vice President, Treasurer, Since 2015
Salary: $375,000.00
Bonus: $450,000.00
David Colleran
Senior Vice President, General Counsel, Secretary, Since 2015
Salary: --
Bonus: --
Aiman Abdel-Malek
Senior Vice President - Advanced Technology and Engineering, Since 2016
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

600 Technology Park Dr Ste 200
BILLERICA   MA   01821-4126

Phone: +1978.6007000

Insulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System (the OmniPod System), an insulin delivery system for people with insulin-dependent diabetes. The Omnipod System features a self-adhesive disposable tubeless Omnipod device, which is worn on the body for approximately three days at a time and its wireless companion, the handheld Personal Diabetes Manager (PDM). The Omnipod System features two discreet devices that eliminate the need for a bulky pump, tubing and separate blood glucose meter, provides for virtually pain-free automated cannula insertion, communicates wirelessly and integrates a blood glucose meter. The Omnipod System is a discreet two part design, the Omnipod device (Pod) and the PDM that eliminates the need for the external tubing required with conventional pumps. The Pod is a self-adhesive device that the patient fills with insulin and wears directly on the body.

SPONSORED STORIES